SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parabolic Drugs informs about board meeting

17 May 2017 Evaluate

Pursuant to the Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parabolic Drugs has informed that a meeting of the Board of Directors of the company is scheduled to be held on Monday, the 29th day of May, 2017, to consider and approve the Audited Financial Results for the Year ended on 31st March, 2017. Pursuant to this, the Company has decided that the close period (i.e. closure of trading window) under the Company’s code of conduct for prevention of Insider Trading would commence from May 18, 2017 and end 24 hours after the results are made public on May 29, 2017.

The above information is a part of company’s filings submitted to BSE.

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×